Keywords = COVID-19
Number of Articles: 15
1. Favipiravir Effects on the Control of Clinical Symptoms of Hospitalized COVID-19 Cases: An Experience with Iranian Formulated Dosage Form

Volume 20, Issue 4, Autumn 2021, Pages 1-8

Payam Tabarsi; Hossein Vahidi; Ali Saffaei; Seyed Mohammad Reza Hashemian; Hamidreza Jamaati; Bahram Daraei; Arash Mahboubi; Farzad Kobarfard; Majid Marjani; Afshin Moniri; Zahra Abtahian; Atefeh Abedini; Alireza Eslaminejad; Jalal Heshmatnia; Maryam Sadat Mirenayat; Atefeh Fakharian; Sharareh Seifi; Mohsen Sadeghi; Alireza Dastan; Sara Haseli; Seyed Alireza Nadji; Raha Eskandari; Sahar Yousefian; Mohammad Varahram; Alireza Zali; Ali Akbar Velayati; Farzaneh Dastan

2. Can Carbon Quantum Dots (CQDs) or Boron Compounds be an Ultimate Solution for COVID-19 Therapy?

Volume 20, Issue 4, Autumn 2021, Pages 9-20

Gamze Camlık; Esra Kupeli Akkol; Zelihagul Değim; Ismail Tuncer Degim

3. An In-silico Screening Strategy to the Prediction of New Inhibitors of COVID-19 Mpro Protein

Volume 20, Issue 4, Autumn 2021, Pages 125-136

Maryam Abbasi; Hojjat Sadeghi-Aliabadi

4. Comparison of the Efficacy and Safety of Atazanavir/Ritonavir Plus Hydroxychloroquine with Lopinavir/Ritonavir Plus Hydroxychloroquine in Patients with moderate COVID-19, A Randomized, Double-blind Clinical Trial

Volume 20, Issue 4, Autumn 2021, Pages 278-288

Zahra Nekoukar; Shahram Ala; Siavash Moradi; Andrew Hill; Ali Reza Davoudi Badabi; Ahmad Alikhani; Shahriar Alian; Minoo Moghimi; Amir Mohammad Shabani; Hamideh Abbaspour Kasgari

5. Achieving Equitable Access to Medicines and Health Services: a COVID-19-time Recalled Matter

Volume 20, Issue 4, Autumn 2021, Pages 450-466

Taraneh Mousavi; Shekoufeh Nikfar; Mohammad Abdollahi

6. Psychiatric Adverse Drug Reactions and Potential Anti-COVID-19 Drug Interactions with Psychotropic Medications

Volume 20, Issue 3, Summer 2021, Pages 66-77

Parisa Ghasemiyeh; Negar Mortazavi; Iman Karimzadeh; Afsaneh Vazin; Laleh Mahmoudi; Ebrahim Moghimi Sarani; Ashkan MohammadSadeghi; Mina Shahisavandi; Ali Kheradmand; Soliman Mohammadi-Samani

7. Private Demand for Covid-19 Vaccine: A Contingent Assessment from a Low-and Middle-income Country

Volume 20, Issue 3, Summer 2021, Pages 223-234

Zahra Meshkani; Leila Zarei; Narges Hajimoladarvish; Jalal Arabloo; Aziz Rezapour; Hiro Farabi; Najmeh Moradi

8. Different Respiratory Samples for COVID-19 Detection by Standard and Direct Quantitative RT-PCR: A Literature Review

Volume 20, Issue 3, Summer 2021, Pages 285-299

Maryam Ahmadzadeh; Hossein Vahidi; Arash Mahboubi; Fariba Hajifathaliha; Leila Nematollahi; Elham Mohit

9. The SARS-Cov-2 Proliferation Blocked by a Novel and Potent Main Protease Inhibitor via Computer-aided Drug Design

Volume 20, Issue 3, Summer 2021, Pages 399-418

Sepideh Shayan; Shahab Jamaran; Rafee Habib Askandar; Arian Rahimi; Azam Elahi; Chiako Farshadfar; Noeman Ardalan

10. Anti-inflammatory Effect of Metronidazole in Hospitalized Patients with Pneumonia due to COVID-19

Volume 20, Issue 3, Summer 2021, Pages 532-540

Muhanna Kazempour; Hossein Izadi; Arezoo Chouhdari; Morteza Rezaeifard

11. The Effect of Exogenous Surfactant on Moderate and Severe Stages of COVID-19 Induced ARDS: the Pilot Study of a Clinical Trial

Volume 20, Issue 3, Summer 2021, Pages 553-559

Kamal Fani; Mehdi Ghahremani; Mohammad Fathi; Nilofar Massoudi; Sasan Tavana; Navid Nooraee; Nasser Malekpour Alamdari; Sara Besharat; Arash Najafi Abrandabadi; Ali Pirsalehi; Mohammad Ali Khabiri Khatiri; Maryam Amini Pouya; Samira Rajaei; Ali Dabbagh

12. Approaches for the Treatment of SARS-CoV-2 Infection: A Pharmacologic View and Literature Review

Volume 19, Issue 3, Summer 2020, Pages 258-281

Hajar Mohammadi Barzelighi; Bahram Daraei; Farzaneh Dastan

13. COVID-19 in Iran: A model for Crisis Management and Current Experience

Volume 19, Issue 2, Spring 2020, Pages 1-8

Hamidreza Jamaati; Farzaneh Dastan; Shirin Esmaili dolabi; Mohammad Varahram; Seyed MohammadReza Hashemian; Shamsi Nasirirayeini; Behrooz farzanegan; Fateme monjazebi

14. Thalidomide against Coronavirus Disease 2019 (COVID-19): A Medicine with a Thousand Faces

Volume 19, Issue 1, Winter 2020, Pages 1-2

Farzaneh Dastan; Payam Tabarsi; Majid Marjani; Afshin Moniri; Seyed MohammadReza Hashemian; Maria Tavakoli-Ardakani; Ali Saffaei

15. A Fourteen-day Experience with Coronavirus Disease 2019 (COVID-19) Induced Acute Respiratory Distress Syndrome (ARDS): An Iranian Treatment Protocol

Volume 19, Issue 1, Winter 2020, Pages 31-36

Hamidreza Jamaati; Farzaneh Dastan; Payam Tabarsi; Majid Marjani; Ali Saffaei; Seyed MohammadReza Hashemian

Iranian Journal of Pharmaceutical Research

Journal Archive